Crossmark

Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials

Crossref DOI link: https://doi.org/10.1186/s12933-019-0834-0

Published Online: 2019-02-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanaka, Atsushi http://orcid.org/0000-0003-3352-7661
Node, Koichi
Funding

Funding for this research was provided by:

Mitsui and Company
License Information

Text and Data Mining valid from 2019-02-28
More Information

Article History

Received: 13 February 2019

Accepted: 19 February 2019

First Online: 28 February 2019